Dr. Magdalena Renne, a leading expert in 3D organoid systems, details how her team has overcome longstanding barriers in ...

For people with macular telangiectasia type 2 (MacTel), an orphan retinal disorder that gradually destroys central vision, ...

A groundbreaking study titled "An Engineered Intravitreal Injection Retinal-Pigment-Epithelium-Tropic Adeno-Associated Virus ...

Stem cell research is at the edge of contemporary medicine, where scientists have shown great hope that it brings the ...

In July 2025, Novartis Pharmaceuticals organized a study is to assess the effect of Iptacopan to prevent conversion of early ...

Novel allogeneic stem cells and differentiated iPSCs are providing more physiologically relevant disease models.

The development of drug delivery platforms that offer sustained release of therapeutic agents in the retina represents a ...

Ocugen says it is on track to reshape the market for gene therapies against eye disorders over the next three years, by ...

Vitamin A, crucial for vision, immunity, and organ function, isn't produced by the body and must be obtained through diet.

In July 2025, Novartis Pharmaceuticals conducted a study is to assess the effect of Iptacopan to prevent conversion of early ...

CARLSBAD, CA, USA I August 04, 2025 I Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel ...

This study offers useful findings demonstrating the cartilage-protective effects of osteoactivin in inflammatory experimental models. The study provides compelling evidence that osteoactivin may serve ...